Episode Details
Back to Episodes
ACR2021 - Day5a
Episode 845
Published 4 years, 6 months ago
Description
Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim
Potpourri of Biosimilar Trials: Dr. Jonathan Kay
Closing a Chapter: Interview with the 84th ACR President 2020-2021, Kathryn Dao